Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Schernthaner, Guntram, Currie, Craig J., Schernthaner, Gerit-Holger
Format: Artigo
Jezik:Inglês
Izdano: American Diabetes Association 2013
Teme:
Diabetes Therapy
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3920795/
https://ncbi.nlm.nih.gov/pubmed/23882041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dcS13-2031
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki